1a87
From Proteopedia
(Difference between revisions)
| Line 3: | Line 3: | ||
<StructureSection load='1a87' size='340' side='right'caption='[[1a87]], [[Resolution|resolution]] 3.10Å' scene=''> | <StructureSection load='1a87' size='340' side='right'caption='[[1a87]], [[Resolution|resolution]] 3.10Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>[[1a87]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/ | + | <table><tr><td colspan='2'>[[1a87]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Escherichia_coli_K-12 Escherichia coli K-12]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1A87 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=1A87 FirstGlance]. <br> |
| - | </td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=1a87 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1a87 OCA], [https://pdbe.org/1a87 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=1a87 RCSB], [https://www.ebi.ac.uk/pdbsum/1a87 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=1a87 ProSAT]</span></td></tr> | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 3.1Å</td></tr> |
| + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=1a87 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1a87 OCA], [https://pdbe.org/1a87 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=1a87 RCSB], [https://www.ebi.ac.uk/pdbsum/1a87 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=1a87 ProSAT]</span></td></tr> | ||
</table> | </table> | ||
== Function == | == Function == | ||
| - | + | [https://www.uniprot.org/uniprot/CEAN_ECOLX CEAN_ECOLX] This colicin is a channel-forming colicin. This class of transmembrane toxins depolarize the cytoplasmic membrane, leading to dissipation of cellular energy. Colicins are polypeptide toxins produced by and active against E.coli and closely related bacteria. | |
== Evolutionary Conservation == | == Evolutionary Conservation == | ||
[[Image:Consurf_key_small.gif|200px|right]] | [[Image:Consurf_key_small.gif|200px|right]] | ||
| Line 18: | Line 19: | ||
</jmol>, as determined by [http://consurfdb.tau.ac.il/ ConSurfDB]. You may read the [[Conservation%2C_Evolutionary|explanation]] of the method and the full data available from [http://bental.tau.ac.il/new_ConSurfDB/main_output.php?pdb_ID=1a87 ConSurf]. | </jmol>, as determined by [http://consurfdb.tau.ac.il/ ConSurfDB]. You may read the [[Conservation%2C_Evolutionary|explanation]] of the method and the full data available from [http://bental.tau.ac.il/new_ConSurfDB/main_output.php?pdb_ID=1a87 ConSurf]. | ||
<div style="clear:both"></div> | <div style="clear:both"></div> | ||
| - | <div style="background-color:#fffaf0;"> | ||
| - | == Publication Abstract from PubMed == | ||
| - | BACKGROUND: Pore-forming colicins are water-soluble bacteriocins capable of binding to and translocating through the Escherichia coli cell envelope. They then undergo a transition to a transmembrane ion channel in the cytoplasmic membrane leading to bacterial death. Colicin N is the smallest pore-forming colicin known to date (40 kDa instead of the more usual 60 kDa) and the crystal structure of its membrane receptor, the porin OmpF, is already known. Structural knowledge of colicin N is therefore important for a molecular understanding of colicin toxicity and is relevant to toxic mechanisms in general. RESULTS: The crystal structure of colicin N reveals a novel receptor-binding domain containing a six-stranded antiparallel beta sheet wrapped around the 63 A long N-terminal alpha helix of the pore-forming domain. The pore-forming domain adopts a ten alpha-helix bundle that has been observed previously in the pore-forming domains of colicin A, la and E1. The translocation domain, however, does not appear to adopt any regular structure. Models for receptor binding and translocation through the outer membrane are proposed based on the structure and biochemical data. CONCLUSIONS: The colicin N-ompF system is now the structurally best-defined translocation pathway. Knowledge of the colicin N structure, coupled with the structure of its receptor, OmpF, and previously published biochemical data, limits the numerous possibilities of translocation and leads to a model in which the translocation domain inserts itself through the porin pore, the receptor-binding domain stays outside and the pore-forming domain translocates along the outer wall of the trimeric porin channel. | ||
| - | |||
| - | Crystal structure of a colicin N fragment suggests a model for toxicity.,Vetter IR, Parker MW, Tucker AD, Lakey JH, Pattus F, Tsernoglou D Structure. 1998 Jul 15;6(7):863-74. PMID:9687368<ref>PMID:9687368</ref> | ||
| - | |||
| - | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | ||
| - | </div> | ||
| - | <div class="pdbe-citations 1a87" style="background-color:#fffaf0;"></div> | ||
==See Also== | ==See Also== | ||
*[[Colicin 3D structures|Colicin 3D structures]] | *[[Colicin 3D structures|Colicin 3D structures]] | ||
| - | == References == | ||
| - | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
| - | [[Category: | + | [[Category: Escherichia coli K-12]] |
[[Category: Large Structures]] | [[Category: Large Structures]] | ||
| - | [[Category: Lakey | + | [[Category: Lakey JH]] |
| - | [[Category: Parker | + | [[Category: Parker MW]] |
| - | [[Category: Pattus | + | [[Category: Pattus F]] |
| - | [[Category: Tsernoglou | + | [[Category: Tsernoglou D]] |
| - | [[Category: Tucker | + | [[Category: Tucker AD]] |
| - | [[Category: Vetter | + | [[Category: Vetter IR]] |
| - | + | ||
| - | + | ||
| - | + | ||
Current revision
COLICIN N
| |||||||||||


